ALG8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.733640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.122770E-01
Normal-vs-Stage2
1.529600E-01
Normal-vs-Stage3
8.480800E-01
Normal-vs-Stage4
4.574400E-01
Stage1-vs-Stage2
5.659200E-01
Stage1-vs-Stage3
1.710350E-01
Stage1-vs-Stage4
3.410600E-01
Stage2-vs-Stage3
1.651160E-01
Stage2-vs-Stage4
4.609600E-01
Stage3-vs-Stage4
6.404600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.914200E-01
Normal-vs-AfricanAmerican
9.130000E-02
Normal-vs-Asian
2.155400E-01
Caucasian-vs-AfricanAmerican
6.624000E-02
Caucasian-vs-Asian
7.708000E-01
AfricanAmerican-vs-Asian
2.604800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.884800E-01
Normal-vs-Female
1.648650E-01
Male-vs-Female
9.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.598600E-01
Normal-vs-Age(41-60Yrs)
3.028400E-02
Normal-vs-Age(61-80Yrs)
3.074000E-01
Normal-vs-Age(81-100Yrs)
1.294010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.094220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.783200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.804000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.280600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.368400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.542400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.916170E-01
Normal-vs-Daily Drinker
3.336000E-01
Normal-vs-Weekly Drinker
2.346000E-01
Normal-vs-Occasional Drinker
8.753600E-02
Normal-vs-Social Drinker
1.613550E-01
Non Drinker-vs-Daily Drinker
7.738600E-01
Non Drinker-vs-Weekly Drinker
8.550000E-01
Non Drinker-vs-Occasional Drinker
7.516400E-01
Non Drinker-vs-Social Drinker
8.757200E-01
Daily Drinker-vs-Weekly Drinker
9.391600E-01
Daily Drinker-vs-Occasional Drinker
5.939400E-01
Daily Drinker-vs-Social Drinker
7.110600E-01
Weekly Drinker-vs-Occasional Drinker
6.426800E-01
Weekly Drinker-vs-Social Drinker
7.643200E-01
Occasional Drinker-vs-Social Drinker
8.973200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.315400E-01
Normal-vs-Grade 2
9.802600E-01
Normal-vs-Grade 3
9.386400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.308200E-02
Grade 1-vs-Grade 3
1.964270E-02
Grade 1-vs-Grade 4
9.315400E-01
Grade 2-vs-Grade 3
2.835200E-01
Grade 2-vs-Grade 4
9.802600E-01
Grade 3-vs-Grade 4
9.386400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.707800E-01
Normal-vs-NonDiabetic
1.479250E-01
Diabetic-vs-NonDiabetic
3.884400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.287500E-02
Normal-vs-NoPancreatitis
2.083000E-01
Pancreatitis-vs-NoPancreatitis
6.872200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.396440E-01
Normal-vs-N1
1.792400E-01
N0-vs-N1
5.340200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.423800E-02
Normal-vs-TP53-NonMutant
3.909200E-01
TP53-Mutant-vs-TP53-NonMutant
7.53199999999898E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
